menu

Education:

Talk about prostate health tulsa procedure profound medical

Talking to your partner about his prostate health

It’s not an easy conversation to have, but speaking to your partner about his prostate health will help him feel supported and heard. Men have a 1 in 6 chance of being diagnosed with prostate cancer, highlighting the importance for men and their partners to educate themselves about the disease, treatment options, and how it […]

Read more

A Milestone in Palliative Care for Metastatic Cancer!

For over a decade, the Busch Center treatment team has strived to change the standard of care for prostate cancer by taking an innovative, radiation-free approach to prostate cancer therapies. Last week, they became the very first prostate treatment center in the U.S. to perform the TULSA Procedure on a patient with metastatic prostate cancer […]

Read more

How to Interpret a Scientific Paper

Often, physicians, and scientists conduct clinical trials to better evaluate a product, procedure, and/or treatment effectiveness. These studies and their outcomes are typically published as scientific papers in academic journals to inform their peers within the scientific community. But these articles can also serve as a valuable resource to patients, presenting information about available treatment […]

Read more
Blog image prostate cancer in black patients med 1920x1008

Prostate Cancer in Black Men

In the United States, approximately 1 in 8 men will be diagnosed with prostate cancer in their lifetime1. The risk of developing prostate cancer is greater in African American men, and they are more than twice as likely to die from the disease. African American men are at greater risk of being diagnosed with prostate […]

Read more
Building bridges blue2

The TULSA Procedure Builds Bridges

The TULSA Procedure is a minimally invasive procedure that uses magnetic resonance (MR) imaging-guided transurethral ultrasound to ablate prostate tissue. This procedure is customizable, predictable, incision-free, and has been shown in a multi-national phase 1 study (30 patients)1 and a subsequent Pivotal study (115 patients)2 to be feasible, safe and a well-tolerated option for localized […]

Read more